Preventing the recurrence of misconduct involving contract testing data and restoring trust
First written in FY2025. 3 of 5 entries say "Advanced", first in 2026-05-13. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Accordingly, taking into account guidance from the relevant authorities and recommendations from external experts, the Company has formulated measures to prevent recurrence centered on (i) information sharing among departments and improvements to the organizational culture, (ii) a review of the training framework, (iii) strengthening its response to DI, and (iv) a review of the testing investigation methods used by the QAU (Quality Assurance Unit), and is revising the relevant SOPs (Standard Operating Procedures).」
Based on its analysis of the causes of the misconduct, the Company has moved into the implementation stage for measures to prevent recurrence, including information sharing, training, DI, QAU investigations and SOP revisions. - FY2025First statedAnnual report
「In June 2025, based on the causes of the misconduct, the Company formulated measures to prevent recurrence comprising (i) establishing a system for reviewing testing reports, centered on revising standard operating procedures and introducing systems to address DI (Data Integrity), and (ii) understanding and verifying the profiles of personnel involved in testing and raising their compliance awareness. The Company will work to restore and enhance the reliability of the Group by promptly implementing these initiatives.」
In June 2025, the Company formulated measures to prevent recurrence covering the revision of standard operating procedures, introduction of a DI-compliant system, establishment of a testing report review framework, understanding and verification of personnel, and compliance awareness initiatives, and has committed to restoring trust through their implementation.